Investor Presentaiton

لله 13 2Q15 Domestic Market Highlights 2Q15 China sales increased 0.9% year-over-year. Overall market continued to be slow and impacted our domestic sales performance. IVD reagents rose further. With a growing installation base for high-speed reagent- consuming products, we remain optimistic about the prospects of this business. We continue to anticipate modest market growth in the foreseeable future. Meanwhile, we also see growing competition in the domestic market from both our local and international competitors. We expect government initiatives and policies (eg. Improving county-level hospitals, priority purchase from local manufacturers, private hospital development, etc.) to be favorable for us over the long run. mindray

View entire presentation